Astec Lifesciences
ASTEC.NS
$13.15
Share price
1.48%
Change (1 day)
-31.96%
Change (1 year)
Categories
Operating Margin for Astec Lifesciences (ASTEC.NS)
Operating Margin as of March 2025 (TTM): -30.38%
According to Astec Lifesciences 's latest financial reports and stock price the company's current Operating Margin is -30.38%. At the end of 2024 the company had an Operating Margin of -13.48%.
Operating Margin history for Astec Lifesciences from 2012 to 2024
Operating Margin at the end of each year
| Year | Operating Margin | Change |
|---|---|---|
| 2024 | -13.48% | -342.24% |
| 2023 | 5.56% | -68.92% |
| 2022 | 17.90% | 11.53% |
| 2021 | 16.05% | 36.74% |
| 2020 | 11.74% | -9.51% |
| 2019 | 12.97% | -15.87% |
| 2018 | 15.42% | 57.95% |
| 2017 | 9.76% | 83.08% |
| 2016 | 5.33% | 13.14% |
| 2015 | 4.71% | -12.5% |
| 2014 | 5.39% | 8.14% |
| 2013 | 4.98% | 210.3% |
| 2012 | 1.61% | -74.8% |
| 2011 | 6.37% | -58.48% |
| 2010 | 15.35% | 4.34% |
| 2009 | 14.71% | -14.11% |
| 2008 | 17.12% |
What is a company's Operating Margin?
The operating margin is a key indicator to assess the profitability of a company. Higher operating margins are generaly better as they show that a company is able to sell its products or services for much more than their production costs. The operating margin is calculated by dividing a company's earnings by its revenue.